Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma

This study has been completed.
Information provided by Corixa Corporation

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Mantle Cell Lymphoma
2		Additional conditions recognized in this trial
			Lymphoma
			Lymphoma, Mantle-Cell
3		More general conditions related to this trial
			Immune System Diseases
			Immunoproliferative Disorders
			Lymphatic Diseases
			Lymphoma, Non-Hodgkin
			Lymphoproliferative Disorders
			Neoplasms
			Neoplasms by Histologic Type
4		Interventions listed in this trial
			Iodine-131 Anti-B1 Antibody
5		Additional drug interventions recognized in this trial
			Antibodies
			Antibodies, Monoclonal
			Cyclophosphamide
			Iodine
6		More general drug interventions related to this trial
			Alkylating Agents
			Anti-Infective Agents
			Anti-Infective Agents, Local
			Antineoplastic Agents
			Antineoplastic Agents, Alkylating
			Antirheumatic Agents
			Growth Substances
			Immunologic Factors
			Immunosuppressive Agents
			Micronutrients
			Molecular Mechanisms of Pharmacological Action
			Myeloablative Agonists
			Pharmacologic Actions
			Physiological Effects of Drugs
			Therapeutic Uses
			Trace Elements
7		Sponsors listed in this trial
			Corixa Corporation